Literature DB >> 3260275

Observations favouring Pneumocystis carinii pneumonia as a primary infection: a monoclonal antibody study on paraffin sections.

P R Millard1, A R Heryet.   

Abstract

Pneumocystis carinii pneumonia is characteristic of immunodeficiency and the organism is probably acquired during early childhood. Since infection is only manifest in the lungs, it has been presumed that the organism lies dormant in these tissues following the primary infection. Conventional staining procedures have, however, failed in the absence of pneumonia to demonstrate consistently any forms of Pneumocystis carinii. To study this problem further, lung sections and hilar lymph nodes from immunodepressed adults with and without Pneumocystis carinii pneumonia as well as lung sections from presumed immunocompetent patients were examined for the cyst and trophozoite forms of Pneumocystis carinii using a monoclonal antibody. The organism was only identified in areas of pneumonia, and the source of the organism in these patients may therefore be a new infection with a different human subtype and not, as previously thought, reactivation of a primary infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260275     DOI: 10.1002/path.1711540413

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Magnetic bead capture eliminates PCR inhibitors in samples collected from the airborne environment, permitting detection of Pneumocystis carinii DNA.

Authors:  N Maher; H K Dillon; S H Vermund; T R Unnasch
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

Review 2.  Extrapulmonary pneumocystosis.

Authors:  V L Ng; D M Yajko; W K Hadley
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 3.  AIDS and the lung: update 1992. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

4.  Application and staining patterns of commercial anti-Pneumocystis carinii monoclonal antibodies.

Authors:  K Elvin; E Linder
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

5.  Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups.

Authors:  A Sing; K Trebesius; A Roggenkamp; H Rüssmann; K Tybus; F Pfaff; J R Bogner; C Emminger; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 6.  Pneumocystis carinii: what is it, exactly?

Authors:  J R Stringer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora.

Authors:  A E Wakefield
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups.

Authors:  M Weig; H Klinker; B H Bögner; A Meier; U Gross
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

9.  Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit.

Authors:  C Hennequin; B Page; P Roux; C Legendre; H Kreis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 10.  Is Pneumocystis carinii a deep mycosis-like agent?

Authors:  E Dei-Cas; J C Cailliez; F Palluault; E M Aliouat; E Mazars; B Soulez; J Suppin; D Camus
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.